During the last session, Agilon Health Inc (NYSE:AGL)’s traded shares were 4.62 million, with the beta value of the company hitting 0.54. At the end of the trading day, the stock’s price was $2.55, reflecting an intraday gain of 3.66% or $0.09. The 52-week high for the AGL share is $18.37, that puts it down -620.39 from that peak though still a striking 7.45% gain since the share price plummeted to a 52-week low of $2.36. The company’s market capitalization is $1.05B, and the average intraday trading volume over the past 10 days was 3.87 million shares, and the average trade volume was 4.37 million shares over the past three months.
Agilon Health Inc (AGL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.74. AGL has a Sell rating from 0 analyst(s) out of 10 analysts who have looked at this stock. 3 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Agilon Health Inc (NYSE:AGL) trade information
Agilon Health Inc (AGL) registered a 3.66% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 3.66% in intraday trading to $2.55, hitting a weekly high. The stock’s 5-day price performance is -5.20%, and it has moved by -28.77% in 30 days. Based on these gigs, the overall price performance for the year is -85.83%. The short interest in Agilon Health Inc (NYSE:AGL) is 35.88 million shares and it means that shorts have 7.39 day(s) to cover.
The consensus price target of analysts on Wall Street is $4, which implies an increase of 36.25% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.5 and $6.5 respectively. As a result, AGL is trading at a discount of -154.9% off the target high and 1.96% off the low.
Agilon Health Inc (AGL) estimates and forecasts
Statistics show that Agilon Health Inc has outperformed its competitors in share price, compared to the industry in which it operates. Agilon Health Inc (AGL) shares have gone down -47.20% during the last six months, with a year-to-date growth rate more than the industry average at 15.22% against 8.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 7.65%. While earnings are projected to return 25.75% in 2024.
AGL Dividends
Agilon Health Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Agilon Health Inc (NYSE:AGL)’s Major holders
Agilon Health Inc insiders own 1.79% of total outstanding shares while institutional holders control 111.48%, with the float percentage being 113.51%. CLAYTON, DUBILIER & RICE, LLC is the largest shareholder of the company, while 295.0 institutions own stock in it. As of 2024-06-30, the company held over 100.0 million shares (or 24.3149% of all shares), a total value of $654.0 million in shares.
The next largest institutional holding, with 56.93 million shares, is of FMR LLC’s that is approximately 13.8418% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $372.3 million.
